These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26607917)

  • 1. Lesions of uncertain malignant potential in the breast (B3): what do we know?
    Purushothaman HN; Lekanidi K; Shousha S; Wilson R
    Clin Radiol; 2016 Feb; 71(2):134-40. PubMed ID: 26607917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of breast lesions of "uncertain malignant potential" and "suspicious for malignancy" determined by needle core biopsy.
    Dillon MF; McDermott EW; Hill AD; O'Doherty A; O'Higgins N; Quinn CM
    Ann Surg Oncol; 2007 Feb; 14(2):704-11. PubMed ID: 17151788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening.
    Rakha EA; Lee AH; Jenkins JA; Murphy AE; Hamilton LJ; Ellis IO
    Int J Cancer; 2011 Sep; 129(6):1417-24. PubMed ID: 21128240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening.
    El-Sayed ME; Rakha EA; Reed J; Lee AH; Evans AJ; Ellis IO
    Histopathology; 2008 Dec; 53(6):650-7. PubMed ID: 19076681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lesions of "uncertain malignant potential" in the breast (B3) identified with mammography screening.
    Richter-Ehrenstein C; Maak K; Röger S; Ehrenstein T
    BMC Cancer; 2018 Aug; 18(1):829. PubMed ID: 30115017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of breast imaging in predicting outcome of lesions of uncertain malignant potential (B3) diagnosed at core needle biopsy.
    Petrovecki M; Alduk AM; Jakic-Razumovic J; Stern-Padovan R; Bubic V; Prutki M
    Tumori; 2016; 102(2):203-8. PubMed ID: 26350202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of needle core biopsy with excision histology in screen-detected B3 lesions: the Merrion Breast Screening Unit experience.
    Hayes BD; O'Doherty A; Quinn CM
    J Clin Pathol; 2009 Dec; 62(12):1136-40. PubMed ID: 19946101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of breast lesions diagnosed as lesion of uncertain malignant potential (B3) or suspicious of malignancy (B4) on needle core biopsy, including detailed review of epithelial atypia.
    Rakha EA; Ho BC; Naik V; Sen S; Hamilton LJ; Hodi Z; Ellis IO; Lee AH
    Histopathology; 2011 Mar; 58(4):626-32. PubMed ID: 21371081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignancy rates of B3-lesions in breast magnetic resonance imaging - do all lesions have to be excised?
    Preibsch H; Wanner LK; Staebler A; Hahn M; Siegmann-Luz KC
    BMC Med Imaging; 2018 Sep; 18(1):27. PubMed ID: 30200900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large volume "mammotome" biopsy may reduce the need for diagnostic surgery in papillary lesions of the breast.
    Carder PJ; Khan T; Burrows P; Sharma N
    J Clin Pathol; 2008 Aug; 61(8):928-33. PubMed ID: 18495791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Borderline breast core needle histology: predictive values for malignancy in lesions of uncertain malignant potential (B3).
    Houssami N; Ciatto S; Bilous M; Vezzosi V; Bianchi S
    Br J Cancer; 2007 Apr; 96(8):1253-7. PubMed ID: 17438578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and management of benign, atypical, and indeterminate breast lesions detected on core needle biopsy.
    Neal L; Sandhu NP; Hieken TJ; Glazebrook KN; Mac Bride MB; Dilaveri CA; Wahner-Roedler DL; Ghosh K; Visscher DW
    Mayo Clin Proc; 2014 Apr; 89(4):536-47. PubMed ID: 24684875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast.
    Carder PJ; Garvican J; Haigh I; Liston JC
    Histopathology; 2005 Mar; 46(3):320-7. PubMed ID: 15720418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive predictive value of breast lesions of uncertain malignant potential (B3): Can we identify high risk patients? The value of a multidisciplinary team and implications in the surgical treatment.
    M T; A P; F G; D S; S Z; M S
    Surg Oncol; 2016 Jun; 25(2):119-22. PubMed ID: 27312039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal invasive biopsy results of "uncertain malignant potential" in digital mammography screening: high prevalence but also high predictive value for malignancy.
    Weigel S; Decker T; Korsching E; Biesheuvel C; Wöstmann A; Böcker W; Hungermann D; Roterberg K; Tio J; Heindel W
    Rofo; 2011 Aug; 183(8):743-8. PubMed ID: 21506072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on percutaneous needle biopsy of nonmalignant breast lesions.
    Johnson NB; Collins LC
    Adv Anat Pathol; 2009 Jul; 16(4):183-95. PubMed ID: 19546607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic imaging of lobular carcinoma of the breast: mammographic, ultrasonographic and MR findings].
    Bazzocchi M; Facecchia I; Zuiani C; Puglisi F; Di Loreto C; Smania S
    Radiol Med; 2000 Dec; 100(6):436-43. PubMed ID: 11307504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of breast MR imaging for predicting malignancy of histologically borderline lesions diagnosed at core needle biopsy: prospective evaluation.
    Pediconi F; Padula S; Dominelli V; Luciani M; Telesca M; Casali V; Kirchin MA; Passariello R; Catalano C
    Radiology; 2010 Dec; 257(3):653-61. PubMed ID: 20884914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative apparent diffusion coefficient (rADC) in breast lesions of uncertain malignant potential (B3 lesions) and pathologically proven breast carcinoma (B5 lesions) following breast biopsy.
    Nadrljanski MM; Milosevic ZC
    Eur J Radiol; 2020 Mar; 124():108854. PubMed ID: 32007817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: clinical importance.
    Philpotts LE; Shaheen NA; Jain KS; Carter D; Lee CH
    Radiology; 2000 Sep; 216(3):831-7. PubMed ID: 10966718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.